- Home
- CALM vs LNTH Comparison
CALM vs LNTH Comparison
Compare CALM & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CALM | LNTH |
|---|---|---|
| Founded | 1957 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.4B |
| IPO Year | 1996 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CALM | LNTH |
|---|---|---|
| Price | $79.62 | $66.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $97.50 | $78.00 |
| AVG Volume (30 Days) | 989.8K | ★ 1.1M |
| Earning Date | 01-07-2026 | 11-06-2025 |
| Dividend Yield | ★ 10.50% | N/A |
| EPS Growth | ★ 198.25 | N/A |
| EPS | ★ 26.04 | 2.39 |
| Revenue | ★ $4,398,616,000.00 | $1,525,933,000.00 |
| Revenue This Year | N/A | $0.01 |
| Revenue Next Year | N/A | $0.52 |
| P/E Ratio | ★ $3.06 | $27.81 |
| Revenue Growth | ★ 65.80 | 1.95 |
| 52 Week Low | $79.24 | $47.25 |
| 52 Week High | $126.40 | $111.29 |
Technical Indicators
Market Signals| Indicator | CALM | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 31.17 | 65.16 |
| Support Level | $79.24 | $66.20 |
| Resistance Level | $88.05 | $67.45 |
| Average True Range (ATR) | 1.80 | 1.71 |
| MACD | -0.48 | -0.08 |
| Stochastic Oscillator | 2.85 | 75.54 |
Price Performance
Historical ComparisonAbout CALM Cal-Maine Foods Inc.
Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.